155 related articles for article (PubMed ID: 38533063)
1. Predictive value of procollagen c-protease enhancer protein on the prognosis of glioma patients.
Yu L; Hu X; Zhu H
Heliyon; 2024 Mar; 10(6):e28089. PubMed ID: 38533063
[TBL] [Abstract][Full Text] [Related]
2. Procollagen C-protease enhancer protein is a prognostic factor for glioma and promotes glioma development by regulating multiple tumor-related pathways and immune microenvironment.
Zhao Z; Zhao J; Wang Z; Wu Y; Zhang Z; Song Z; Miao J; Liu B; Zhang S; Sun B; Zhao Z
Int J Immunopathol Pharmacol; 2022; 36():3946320221104548. PubMed ID: 35609253
[TBL] [Abstract][Full Text] [Related]
3. High expression of PCOLCE gene indicate poor prognosis in patients and are associated with immune infiltration in glioma.
Guo Q; Gao X; Li J; Liu Y; Liu J; Yang H; Cui M; Zhang M; Duan L; Ma X
Sci Rep; 2023 Mar; 13(1):3820. PubMed ID: 36882457
[TBL] [Abstract][Full Text] [Related]
4. TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment.
Zhu H; Hu X; Gu L; Jian Z; Li L; Hu S; Qiu S; Xiong X
Front Genet; 2021; 12():759953. PubMed ID: 34721547
[TBL] [Abstract][Full Text] [Related]
5. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
6. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Potential of Secreted Modular Calcium-Binding Protein 1 in Low-Grade Glioma.
Wang J; Xia S; Zhao J; Gong C; Xi Q; Sun W
Front Mol Biosci; 2021; 8():666623. PubMed ID: 34869577
[No Abstract] [Full Text] [Related]
8. A pan-cancer analysis of the oncogenic role of procollagen C-endopeptidase enhancer (PCOLCE) in human.
Gao H; Li Q
Medicine (Baltimore); 2022 Dec; 101(52):e32444. PubMed ID: 36596064
[TBL] [Abstract][Full Text] [Related]
9. The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis.
Zhang S; Guo Y; Hu Y; Gao X; Bai F; Ding Q; Hou K; Wang Z; Sun X; Zhao H; Qu Z; Xu Q
Front Immunol; 2023; 14():1242972. PubMed ID: 37809064
[TBL] [Abstract][Full Text] [Related]
10. PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer.
Xiang A; Lin X; Xu L; Chen H; Guo J; Zhou F
Front Mol Biosci; 2020; 7():544895. PubMed ID: 33392251
[TBL] [Abstract][Full Text] [Related]
11. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
[TBL] [Abstract][Full Text] [Related]
12. Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma.
Tan Z; Zhang Z; Yu K; Yang H; Liang H; Lu T; Ji Y; Chen J; He W; Chen Z; Mei Y; Shen XL
Front Neurol; 2022; 13():964590. PubMed ID: 36388191
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of PCOLCE by TWIST1 promotes metastasis in Osteosarcoma.
Wang S; Zhong L; Li Y; Xiao D; Zhang R; Liao D; Lv D; Wang X; Wang J; Xie X; Chen J; Wu Y; Kang T
Theranostics; 2019; 9(15):4342-4353. PubMed ID: 31285765
[TBL] [Abstract][Full Text] [Related]
14. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients.
Zhu H; Hu X; Feng S; Gu L; Jian Z; Zou N; Xiong X
Front Immunol; 2022; 13():946692. PubMed ID: 35928818
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
[TBL] [Abstract][Full Text] [Related]
18. The N6-Methylandenosine-Related Gene
Jiang X; Shi Y; Chen X; Xu H; Huang X; Li L; Pu J
Front Mol Biosci; 2022; 9():773662. PubMed ID: 35309512
[TBL] [Abstract][Full Text] [Related]
19. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
Hao YP; Wang WY; Qiao Q; Li G
Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of transferrin receptor protein 1 for predicting prognosis and immune infiltration in lower grade glioma.
Wu H; He H; Huang J; Wang C; Dong Y; Lin R; Cheng Z; Qiu Q; Hong L
Front Mol Neurosci; 2022; 15():972308. PubMed ID: 36483569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
